Chemo-Pharma [CPL] vs Escorts Kubota [ESCORTS] Detailed Comparison
Chemo-Pharma
BSE
Loading...
Escorts Kubota
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Chemo-Pharma wins in 11 metrics, Escorts Kubota wins in 7 metrics, with 0 ties. Chemo-Pharma appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Chemo-Pharma | Escorts Kubota | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.21 | 34.02 | Chemo-Pharma |
| Price-to-Book Ratio | 2.96 | 3.75 | Chemo-Pharma |
| Debt-to-Equity Ratio | 44.70 | 1.02 | Escorts Kubota |
| PEG Ratio | N/A | 28.79 | N/A |
| EV/EBITDA | 15.63 | 31.48 | Chemo-Pharma |
| Profit Margin (TTM) | 10.92% | 12.35% | Escorts Kubota |
| Operating Margin (TTM) | 10.65% | 9.24% | Chemo-Pharma |
| EBITDA Margin (TTM) | 10.65% | 9.24% | Chemo-Pharma |
| Return on Equity | 25.59% | 11.38% | Chemo-Pharma |
| Return on Assets (TTM) | 6.80% | 4.52% | Chemo-Pharma |
| Free Cash Flow (TTM) | $41.66M | $7.47B | Escorts Kubota |
| Dividend Yield | N/A | 1.38% | N/A |
| 1-Year Return | 38.64% | -17.59% | Chemo-Pharma |
| Price-to-Sales Ratio (TTM) | 1.65 | 3.74 | Chemo-Pharma |
| Enterprise Value | $5.03B | $353.73B | Escorts Kubota |
| EV/Revenue Ratio | 1.75 | 3.45 | Chemo-Pharma |
| Gross Profit Margin (TTM) | 31.19% | 30.63% | Chemo-Pharma |
| Revenue per Share (TTM) | $52 | $932 | Escorts Kubota |
| Earnings per Share (Diluted) | $6.02 | $102.27 | Escorts Kubota |
| Beta (Stock Volatility) | 0.35 | 0.17 | Escorts Kubota |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Chemo-Pharma vs Escorts Kubota Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Chemo-Pharma | -2.35% | 1.69% | 4.48% | -15.16% | -28.20% | -35.30% |
| Escorts Kubota | -0.98% | -0.10% | 3.24% | 2.34% | 1.32% | 3.40% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Chemo-Pharma | 38.64% | 393.51% | 115.30% | 982.62% | 1,384.38% | 1,384.38% |
| Escorts Kubota | -17.59% | 97.13% | 201.25% | 2,315.13% | 1,645.63% | 3,581.25% |
Performance & Financial Health Analysis: Chemo-Pharma vs Escorts Kubota
| Metric | CPL | ESCORTS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.75B | ₹382.71B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 34,895 | 88,411 |
| 90 Day Avg. Volume | 36,751 | 145,554 |
| Last Close | ₹75.25 | ₹3,411.70 |
| 52 Week Range | ₹52.25 - ₹128.00 | ₹2,776.40 - ₹4,420.00 |
| % from 52W High | -41.21% | -22.81% |
| All-Time High | ₹128.00 (Jan 06, 2025) | ₹4,420.00 (Sep 23, 2024) |
| % from All-Time High | -41.21% | -22.81% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.17% |
| Quarterly Earnings Growth | -0.04% | 0.26% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.12% |
| Operating Margin (TTM) | 0.11% | 0.09% |
| Return on Equity (TTM) | 0.26% | 0.11% |
| Debt to Equity (MRQ) | 44.70 | 1.02 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹26.86 | ₹926.62 |
| Cash per Share (MRQ) | ₹1.07 | ₹290.87 |
| Operating Cash Flow (TTM) | ₹89.49M | ₹10.03B |
| Levered Free Cash Flow (TTM) | ₹-72,916,248 | ₹11.03B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.38% |
| Last 12-Month Dividend | ₹0.00 | ₹46.00 |
Valuation & Enterprise Metrics Analysis: Chemo-Pharma vs Escorts Kubota
| Metric | CPL | ESCORTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.21 | 34.02 |
| Forward P/E | N/A | 28.79 |
| PEG Ratio | N/A | 28.79 |
| Price to Sales (TTM) | 1.65 | 3.74 |
| Price to Book (MRQ) | 2.96 | 3.75 |
| Market Capitalization | ||
| Market Capitalization | ₹4.75B | ₹382.71B |
| Enterprise Value | ₹5.03B | ₹353.73B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.75 | 3.45 |
| Enterprise to EBITDA | 15.63 | 31.48 |
| Risk & Other Metrics | ||
| Beta | 0.35 | 0.17 |
| Book Value per Share (MRQ) | ₹26.86 | ₹926.62 |
Financial Statements Comparison: Chemo-Pharma vs Escorts Kubota
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CPL | ESCORTS |
|---|---|---|
| Revenue/Sales | ₹784.51M | ₹24.45B |
| Cost of Goods Sold | ₹539.82M | ₹16.96B |
| Gross Profit | ₹244.69M | ₹7.49B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹83.57M | ₹2.25B |
| EBITDA | ₹98.07M | ₹4.18B |
| Pre-Tax Income | ₹68.08M | ₹3.51B |
| Income Tax | ₹16.93M | ₹791.20M |
| Net Income (Profit) | ₹51.16M | ₹3.18B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CPL | ESCORTS |
|---|---|---|
| Cash & Equivalents | ₹12.05M | ₹3.43B |
| Total Current Assets | ₹2.51B | ₹71.35B |
| Total Current Liabilities | ₹1.17B | ₹24.88B |
| Long-Term Debt | ₹109.50M | ₹677.40M |
| Total Shareholders Equity | ₹1.49B | ₹103.63B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹144.04M | ₹19.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CPL | ESCORTS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CPL | ESCORTS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 34,895 | 88,411 |
| Average Daily Volume (90 Day) | 36,751 | 145,554 |
| Shares Outstanding | 57.55M | 110.00M |
| Float Shares | 15.95M | 31.53M |
| % Held by Insiders | 0.70% | 0.73% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Chemo-Pharma vs Escorts Kubota
| Metric | CPL | ESCORTS |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹46.00 |
| Last 12-Month Dividend Yield | N/A | 1.38% |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹17.67 |
| 3-Year Avg Dividend Yield | N/A | 0.41% |
| 3-Year Total Dividends | ₹0.00 | ₹53.00 |
| Ex-Dividend Date | N/A | Jul 04, 2025 |